New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
15:26 EDTEXPR, DELL, GMCR, CELG, NYCBStocks with expanding option implied volatility; EXPR DELL GMCR CELG NYCB
News For EXPR;DELL;GMCR;CELG;NYCB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
08:55 EDTCELGCelgene price target raised to $115 from $100 at RBC Capital
RBC Capital increased its price target on Celgene (CELG) as the firm now estimates that the company's new oral Crohn's disease drug GED-0301 will generate $1B in sales. The firm expects Celgene's stock to rise further as it predicts that Phase II data for the company's Crohn's treatment will be much better than the data for AbbVie's (ABBV) Crohn's treatment, Humira. RBC predicts that Celgene's long-term 2020 guidance will beat expectations if the company is able to reach a legal settlement with Actavis (ACT.). RBC Capital keeps an Outperform rating on Celgene.
07:26 EDTCELGInforma Business Information to hold a conference
Subscribe for More Information
07:25 EDTDELLOracle to hold a conference
Open World 2014 to be held in San Francisco on September 28-October 2.
September 26, 2014
06:13 EDTGMCRKeurig Green Mountain implied volatility of 31 at lower end of index mean range
September 25, 2014
09:36 EDTCELGActive equity options trading on open
Subscribe for More Information
08:33 EDTGMCRGreen Mountain's Keurig 2.0 launch trends positive, says Longbow
Subscribe for More Information
September 24, 2014
13:17 EDTCELGCelgene continues rally after FDA approval of psoriasis drug
Subscribe for More Information
07:01 EDTCELGCelgene OTEZLA to become important revenue generator, says Cantor
Subscribe for More Information
September 23, 2014
15:21 EDTCELGCelgene announces FDA approves Otezla for treating plaque psoriasis
Subscribe for More Information
10:23 EDTNYCBHigh option volume stocks
Subscribe for More Information
September 22, 2014
07:21 EDTCELGEBD Group to hold a conference
Subscribe for More Information
07:17 EDTGMCRKeurig Green Mountain favorable antitrust ruling was expected, says KeyBanc
Subscribe for More Information
September 19, 2014
17:22 EDTGMCRJudge denies JBR motion blocking sales of Keurig 2.0 brewer, Bloomberg reports
Subscribe for More Information
16:13 EDTGMCRJudge denies JBR motion blocking sales of Keurig 2.0 brewer, Bloomberg reports
10:06 EDTEXPROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:14 EDTEXPRExpress downgraded to Neutral from Buy at Goldman
Goldman downgraded Express to Neutral based on lackluster fundamentals as the pace of promotions in the quarter indicate a less robust margin recovery. The analyst believes shares reflect fundamentals and upside risk of a potential takeover. Price target lowered to $17 from $18.
06:08 EDTGMCRKeurig Green Mountain implied volatility of 29 at lower end of index mean range
Subscribe for More Information
September 17, 2014
07:00 EDTCELGConcert Pharmaceuticals announces initiation of CTP-730 Phase 1 trial
Subscribe for More Information
September 16, 2014
09:56 EDTNYCBNew York Community Bancorp upgraded to Buy from Hold at Standpoint Research

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use